Compare ZJYL & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZJYL | MYO |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.5M | 33.2M |
| IPO Year | 2023 | 2017 |
| Metric | ZJYL | MYO |
|---|---|---|
| Price | $0.24 | $0.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | ★ 1.7M | 754.6K |
| Earning Date | 08-20-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | $22,826,624.00 | ★ $41,643,203.00 |
| Revenue This Year | N/A | $24.69 |
| Revenue Next Year | N/A | $20.91 |
| P/E Ratio | $21.46 | ★ N/A |
| Revenue Growth | 13.42 | ★ 65.00 |
| 52 Week Low | $0.22 | $0.71 |
| 52 Week High | $1.42 | $7.17 |
| Indicator | ZJYL | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 31.88 | 58.91 |
| Support Level | $0.24 | $0.71 |
| Resistance Level | $0.28 | $0.95 |
| Average True Range (ATR) | 0.02 | 0.07 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 9.83 | 95.40 |
Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).